MCAVOY DAVID R. enters ENDOCYTE INC with 24.18K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 11/15/2018ACC: 0001179110-18-012882
Officer· General Counsel
Since Nov 2018
24.18K
Baseline shares
100% direct
24.18K
Direct ownership
1 position
37.50K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned24.18K
Total
24.18K direct24.18K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 24.18K | Direct |
| Total | 24.18K | 24.18K direct |
Derivative Holdings1
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
37.50K
Shares owned
N/A
Exercise price
2.96
Expiration
—
Exercise window
—
Total
Underlying
37.50K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 2.96 | — | — | 37.50K | N/A |
| Total | 37.50K | 0.00 | ||||